Tevogen Selling General Administrative vs Income Tax Expense Analysis
| TVGN Stock | 1.00 0.07 6.54% |
Tevogen Bio financial indicator trend analysis is much more than just breaking down Tevogen Bio Holdings prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Tevogen Bio Holdings is a good investment. Please check the relationship between Tevogen Bio Selling General Administrative and its Income Tax Expense accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tevogen Bio Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
Selling General Administrative vs Income Tax Expense
Selling General Administrative vs Income Tax Expense Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Tevogen Bio Holdings Selling General Administrative account and Income Tax Expense. At this time, the significance of the direction appears to have no relationship.
The correlation between Tevogen Bio's Selling General Administrative and Income Tax Expense is 0.04. Overlapping area represents the amount of variation of Selling General Administrative that can explain the historical movement of Income Tax Expense in the same time period over historical financial statements of Tevogen Bio Holdings, assuming nothing else is changed. The correlation between historical values of Tevogen Bio's Selling General Administrative and Income Tax Expense is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Selling General Administrative of Tevogen Bio Holdings are associated (or correlated) with its Income Tax Expense. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Income Tax Expense has no effect on the direction of Selling General Administrative i.e., Tevogen Bio's Selling General Administrative and Income Tax Expense go up and down completely randomly.
Correlation Coefficient | 0.04 |
| Relationship Direction | Positive |
| Relationship Strength | Insignificant |
Selling General Administrative
Income Tax Expense
Most indicators from Tevogen Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Tevogen Bio Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tevogen Bio Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. At this time, Tevogen Bio's Enterprise Value Over EBITDA is very stable compared to the past year. As of the 11th of December 2024, Enterprise Value Multiple is likely to grow to about 10.2 K, while Selling General Administrative is likely to drop about 1.8 M.
| 2010 | 2022 | 2023 | 2024 (projected) | Reconciled Depreciation | 9.4K | 230.8K | 265.4K | 278.7K | Total Operating Expenses | 4.6M | 953.1K | 2.3M | 2.1M |
Tevogen Bio fundamental ratios Correlations
Click cells to compare fundamentals
Tevogen Bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pair Trading with Tevogen Bio
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Tevogen Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tevogen Bio will appreciate offsetting losses from the drop in the long position's value.Moving against Tevogen Stock
| 0.64 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.36 | LLY | Eli Lilly | PairCorr |
| 0.33 | PFE | Pfizer Inc Fiscal Year End 4th of February 2025 | PairCorr |
The ability to find closely correlated positions to Tevogen Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Tevogen Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Tevogen Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Tevogen Bio Holdings to buy it.
The correlation of Tevogen Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tevogen Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Tevogen Bio Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Tevogen Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tevogen Bio Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tevogen Bio. If investors know Tevogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tevogen Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Return On Assets (0.83) |
The market value of Tevogen Bio Holdings is measured differently than its book value, which is the value of Tevogen that is recorded on the company's balance sheet. Investors also form their own opinion of Tevogen Bio's value that differs from its market value or its book value, called intrinsic value, which is Tevogen Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tevogen Bio's market value can be influenced by many factors that don't directly affect Tevogen Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tevogen Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tevogen Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tevogen Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.